Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding.
Cortes JE, Abruzzese E, Cardonick EH, Hernández-Díaz S, Gutierrez J, Sardegna MS, Torres-Chavez E, Dinatale M, Lerro CC, Gehrke BJ, Shord SS, De Claro RA, Theoret MR, DeMaria PJ, Norsworthy KJ. Cortes JE, et al. Among authors: shord ss. Clin Cancer Res. 2024 Sep 3;30(17):3658-3666. doi: 10.1158/1078-0432.CCR-24-0826. Clin Cancer Res. 2024. PMID: 38967550 Free PMC article. Review.
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs.
Gao W, Liu J, Musante CJ, Zhu H, Thompson M, Shah M, Cao Y, Ivaturi V, Conaway MR, Bottino D, Yin D, Semiond D, Oganesian A, Ratain MJ, Li C, Zhu L, Ou YC, Jiang X, Vallejo J, Madabushi R, Liu Q, Theoret M, Rahman A, Booth B, Okusanya O, Johnson-Williams BE, Shord SS. Gao W, et al. Among authors: shord ss. Clin Pharmacol Ther. 2025 Oct;118(4):772-777. doi: 10.1002/cpt.3725. Epub 2025 Jun 5. Clin Pharmacol Ther. 2025. PMID: 40470834 Review.
FDA Approval Summary: Datopotamab deruxtecan-dlnk for treatment of patients with unresectable or metastatic, HR-positive, HER2-negative breast cancer.
Royce M, Shah M, Zhang L, Cheng J, Bonner MK, Pegues M, Miller CP, Leu L, Price LSL, Qiu J, Yu J, Truong TM, Dorff SE, Yang Y, Zhang N, Gutierrez-Lugo M, Ricks TK, Pierce WF, Luo Z, Kappel D, Goldberg KB, Shord SS, Tang S, Bhatnagar V, Pazdur R, Kluetz PG, Amiri-Kordestani L. Royce M, et al. Among authors: shord ss. Clin Cancer Res. 2025 Aug 27:10.1158/1078-0432.CCR-25-1388. doi: 10.1158/1078-0432.CCR-25-1388. Online ahead of print. Clin Cancer Res. 2025. PMID: 40864501 Free PMC article.
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.
Singh S, Bradford D, Chatterjee S, Li X, Aungst SL, Skinner AM, Miller CP, Kim-McOlash S, Fourie Zirkelbach J, Xiong Y, Bi Y, Wang YH, Yang Y, Sun J, Kraft J, Charlab R, Shord SS, Tang S, Scepura B, Bulatao I, Udoka O, Saber H, Rahman NA, Pazdur R, Singh H, Donoghue M, Drezner N. Singh S, et al. Among authors: shord ss. Clin Cancer Res. 2025 Apr 14;31(8):1383-1389. doi: 10.1158/1078-0432.CCR-24-3439. Clin Cancer Res. 2025. PMID: 39808502 Free PMC article. Clinical Trial.
52 results